Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00401-018-1941-9
PubMed Identifier: 30483944
Publication URI: http://europepmc.org/abstract/MED/30483944
Type: Journal Article/Review
Volume: 137
Parent Publication: Acta neuropathologica
Issue: 3
ISSN: 0001-6322